Device Trial Radar · NCT05245812
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Mar 8, 2022
Primary completion
Feb 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- Deborah Farr, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 18, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci single port (SP) robotic platform to perform robotic nipple sparing mastectomy (rNSM) and immediate breast reconstruction with tissue expanders/implants and acellular dermal matrix (ADM - Alloderm), for patients with breast cancer as well as those with a high risk for breast cancer. Safety and feasibility measures will be measured as primary outcome measures. Oncological and patient satisfaction outcome measures will be measured. Our hypothesis is that SPr-NSM is equal to open NSM in terms of safety, feasibility and oncological outcomes with improved patient satisfaction as measured by nipple sensation and patient reported outcomes.
Conditions
- Breast Cancer
- High Risk of Breast Cancer
Interventions
da Vinci SP Surgical SystemDevice
This is a software-controlled, electro- mechanical system designed for surgeons to perform single port minimally invasive surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants who complete single port nipple sparing mastectomy (SPrNSM)Time frame: Date of surgery (Day 1)
- Incidence of perioperative complicationsTime frame: 30 days following surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UT Southwestern
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.